Itron (NASDAQ:ITRI) Research Coverage Started at Raymond James Financial

Raymond James Financial assumed coverage on shares of Itron (NASDAQ:ITRI) in a research note released on Tuesday, Marketbeat reports. The brokerage issued an underperform rating on the scientific and technical instruments company’s stock.

Several other brokerages have also issued reports on ITRI. Weiss Ratings lowered Itron from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Guggenheim set a $155.00 target price on Itron in a report on Friday, February 13th. Needham & Company LLC started coverage on Itron in a research note on Friday, March 6th. They set a “buy” rating and a $124.00 price target on the stock. Robert W. Baird set a $128.00 price target on Itron and gave the stock an “outperform” rating in a research report on Wednesday, February 18th. Finally, Zacks Research upgraded Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $133.10.

Itron Stock Down 1.2%

ITRI stock opened at $88.56 on Tuesday. The stock has a market cap of $3.92 billion, a P/E ratio of 13.60, a PEG ratio of 0.79 and a beta of 1.50. The company has a current ratio of 1.80, a quick ratio of 1.56 and a debt-to-equity ratio of 0.45. Itron has a twelve month low of $83.51 and a twelve month high of $142.00. The company’s 50 day moving average is $93.01 and its two-hundred day moving average is $100.83.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.19 by $0.27. The business had revenue of $571.66 million during the quarter, compared to analysts’ expectations of $561.31 million. Itron had a net margin of 12.72% and a return on equity of 20.04%. The company’s revenue for the quarter was down 6.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.35 EPS. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. Research analysts expect that Itron will post 5.99 earnings per share for the current fiscal year.

Insider Buying and Selling at Itron

In related news, CFO Joan S. Hooper sold 3,533 shares of the firm’s stock in a transaction dated Thursday, February 26th. The stock was sold at an average price of $95.92, for a total transaction of $338,885.36. Following the transaction, the chief financial officer owned 118,275 shares of the company’s stock, valued at $11,344,938. This trade represents a 2.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO David Marshall Wright sold 264 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $100.17, for a total transaction of $26,444.88. Following the transaction, the chief accounting officer directly owned 9,124 shares of the company’s stock, valued at $913,951.08. This represents a 2.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 51,180 shares of company stock valued at $5,085,475. Corporate insiders own 1.77% of the company’s stock.

Institutional Trading of Itron

Several large investors have recently bought and sold shares of ITRI. Employees Retirement System of Texas acquired a new position in shares of Itron during the 3rd quarter worth $32,000. Private Trust Co. NA grew its stake in Itron by 112.4% in the 4th quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock valued at $25,000 after acquiring an additional 145 shares during the last quarter. Optiver Holding B.V. purchased a new position in Itron during the 3rd quarter valued at about $36,000. Salomon & Ludwin LLC acquired a new stake in shares of Itron in the third quarter valued at approximately $42,000. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in Itron by 343.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock valued at $46,000 after buying an additional 268 shares during the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.